1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Novavax, Inc.
  6. News
  7. Summary
    NVAX   US6700024010


Real-time Estimate Cboe BZX  -  05/17 10:05:43 am EDT
48.53 USD   +1.10%
05/16Novavax Files for Emergency Use Authorization of COVID-19 Vaccine in Taiwan
05/11TRANSCRIPT : Novavax, Inc. Presents at Bank of America 2022 Healthcare Conference, May-11-2022 05:20 PM
05/11SECTOR UPDATE : Health Care Stocks Edging Lower Ahead of Wednesday Close
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Australia says no to 16-year-old forklift drivers as remedy to COVID supply chain pain

01/20/2022 | 12:37am EDT
FILE PHOTO: People are turned away at a COVID-19 testing centre in Western Sydney

SYDNEY (Reuters) - Australia has ruled out letting teenagers as young as 16 drive forklift trucks to tackle a shortage of workers in coronavirus-hit supply chains, as it scrambles to scoop up millions of home testing kits needed to keep businesses functioning.

A sudden surge in coronavirus cases in recent weeks has seen hundreds of thousands of workers benched by illness or the need to isolate, leading states to quickly lower the isolation requirement to seven days.

Prime Minister Scott Morrison had floated a proposal to lower the minimum age of forklift drivers from 18 to 16, seeking solutions for a shortage of workers now hobbling the economy. Earlier this week he scrapped visa fees for foreign backpackers and students wanting to work and study in Australia.

But most States consider forklift operation to be high-risk work which requires a licence available only to 18s and over, and after a meeting with State premiers on Thursday, Morrison said the proposal had proved a non-starter.

"We had a good discussion today and it is not something that we believe, collectively, we should be pursuing at this time," Morrison told a media conference.

The National Cabinet did agree to consider recognising New Zealand licenses for truck drivers to meet a shortage in that sector.

Morrison's Liberal-National coalition government is seeking ways to loosen regulations in Australia's transport and food sectors to ease supply chain and workforce disruptions that have led to empty supermarket shelves.

The problem has been exacerbated by a widespread shortage of rapid antigen tests (RATs), limiting the ability of workers to test themselves, which has become a hot button issue for voters ahead of an election expected by May.

Addressing criticism the government had acted too late on securing RATs, Morrison had on Wednesday promised to procure up to 52 million kits this month and urged state leaders to drop requirements for workers in most industries to take daily tests.

He was upstaged on Thursday by Victoria Premier Dan Andrews, who announced the state had ordered 166 million test kits, on top of 44 million already on the way.

The government is still having to defend its slow start last year to procuring vaccines, blaming a worldwide shortage of shots and the need for the drugs to be properly approved.

Australia's Therapeutic Goods Administration (TGA) on Thursday provisionally approved Novavax Inc's COVID-19 vaccine, and two oral treatments for vulnerable patients.

The country on Thursday reached the grim milestone of 2 million cases since the start of the pandemic, though deaths have been low by international standards at just over 2,900.

The three most populous states of New South Wales, Victoria and Queensland on Thursday reported 69,600 new coronavirus cases and more than 4,800 patients in hospital.

NSW at least did see the first drop in hospitalisations since mid-December, a possible sign the Omicron wave could be peaking in the state.

(Reporting by Wayne Cole; Editing by Kenneth Maxwell)

By Wayne Cole

© Reuters 2022
Stocks mentioned in the article
ChangeLast1st jan.
BELIEVE 1.47% 9.665 Real-time Quote.-43.63%
NOVAVAX, INC. 2.43% 49.65 Delayed Quote.-66.45%
ON SEMICONDUCTOR CORPORATION 4.01% 57.49 Delayed Quote.-18.80%
All news about NOVAVAX, INC.
05/16Novavax Files for Emergency Use Authorization of COVID-19 Vaccine in Taiwan
05/11TRANSCRIPT : Novavax, Inc. Presents at Bank of America 2022 Healthcare Conference, May-11-..
05/11SECTOR UPDATE : Health Care Stocks Edging Lower Ahead of Wednesday Close
05/11SECTOR UPDATE : Health Care Stocks Still Hanging on for Small Advance
05/11B. Riley Lowers Novavax's Price Target to $181 from $203, Keeps Buy Rating
05/10Wall St slips in choppy trading ahead of inflation data
05/10GLOBAL MARKETS LIVE : Bayer, Sony, AMC, Peloton, Tesla...
05/10Novavax Reports Higher Q1 Results; Shares Slump
05/10WALL STREET STOCK EXCHANGE : A little respite for Wall Street
05/10SECTOR UPDATE : Health Care Stocks Climb Premarket Tuesday
More news
Analyst Recommendations on NOVAVAX, INC.
More recommendations
Financials (USD)
Sales 2022 4 285 M - -
Net income 2022 1 969 M - -
Net cash 2022 2 508 M - -
P/E ratio 2022 2,01x
Yield 2022 -
Capitalization 3 750 M 3 750 M -
EV / Sales 2022 0,29x
EV / Sales 2023 0,12x
Nbr of Employees 1 541
Free-Float 99,0%
Duration : Period :
Novavax, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NOVAVAX, INC.
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus BUY
Number of Analysts 6
Last Close Price 48,00 $
Average target price 174,83 $
Spread / Average Target 264%
EPS Revisions
Managers and Directors
Stanley C. Erck President, Chief Executive Officer & Director
James Patrick Kelly Chief Financial Officer, Treasurer & Executive VP
James F. Young Chairman
Gregory M. Glenn President-Research & Development
Biegie Lee Chief Information Officer & Senior Vice President
Sector and Competitors
1st jan.Capi. (M$)
NOVAVAX, INC.-66.45%3 750
MODERNA, INC.-45.70%54 855
LONZA GROUP AG-27.63%40 862
IQVIA HOLDINGS INC.-26.03%39 504
SEAGEN INC.-12.27%24 966